Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award
Professor at Hunan University of Chinese Medicine , China.
Professor Shuanglin Qin , born on October 1, 1989
, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine
. With a Ph.D. in Chemical Biology
, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds
. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award
. Prof. Qin also serves as an editorial member for prestigious journals
and actively contributes to advancing chemical biology and precision medicine
.
PROFILE
Summary of Suitability:
Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine . He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications
. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.
Education &
Experience
Education:
-
2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University
-
2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University
-
2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine
Experience:
-
2024–2025: Professor, Hunan University of Chinese Medicine
-
2019–2024: Associate Professor, Hubei University of Science and Technology
Professional Development 

Professor Shuanglin Qin is committed to continual professional advancement . As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China
. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research
. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination
. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally
.
Research Focus
Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery . He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine
. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors
. His efforts are directed toward developing precision medications with high efficacy and minimal side effects
. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation
. His lab continues to pave the way in translational cancer research and drug development
.
Awards and Honors 

-
Winner, Hunan Science Fund for Distinguished Young Scholars
-
Winner, ChuTian Scholars Program, Hubei Province
-
Principal Investigator, National Natural Science Foundation of China projects
-
Recipient, China Postdoctoral Science Foundation funding
-
Recognized in Youth Talent Programs by Hubei Health Commission & Education Department
-
Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining
-
Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology
Publications & Citations 
-
“Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 |
2025 |
Cited by: 1
-
“PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 |
2025 |
Cited by: 0
-
“Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 |
2024 |
Cited by: 2
-
“PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 |
2025 |
Cited by: 19
Conclusion:
Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.